Delafloxacin In Vitro Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone

Delafloxacin, a recently approved anionic fluoroquinolone, was tested within an international resistance surveillance program. The in vitro susceptibilities of 7,914 indicated pathogens causing acute bacterial skin and skin structure infections (ABSSSI) were determined using Clinical and Laboratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaller, M. A., Flamm, R. K., McCurdy, S. P., Pillar, C. M., Shortridge, D., Jones, R. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Bacteriology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062791/
https://www.ncbi.nlm.nih.gov/pubmed/29848564
http://dx.doi.org/10.1128/JCM.00339-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062791/
https://www.ncbi.nlm.nih.gov/pubmed/29848564
http://dx.doi.org/10.1128/JCM.00339-18

Ejemplares similares